mspielmann.bsky.social

mspielmann.bsky.social

@mspielmann.bsky.social

309 followers252 following7 posts

mspielmann.bsky.social reposted

mspielmann.bsky.social reposted

Replying to @alleninstitute.org

A map of normal development gives researchers a baseline for understanding birth defects, cancer, and more, revealing when and where cells go off course. The full tree is public via an interactive browser called NextCell: nextcell.seattlehub.org

nextcell.seattlehub.orgNextCell — every cell in one mouse embryo, traced back to the zygoteAn interactive browser for the lineage tree of 1,281,141 cells from one mouse embryo, recorded with DNA Typewriter and dated from the zygote to E13.5.

mspielmann.bsky.social reposted

📣 Interested in non-coding disease-causing variants? Check out our review "Mechanisms underlying disease-causing variants in promoters and enhancers". Interesting mechanisms, challenges and future perspectives. Great to work with @wbickmor.bsky.social, Kun and Ryan! www.nature.com/articles/s41...

nature.comMechanisms underlying disease-causing variants in promoters and enhancers - Nature GeneticsThis Review discusses how rare-disease-causing variants in the noncoding genome impact gene regulation, why these examples are so few and how new approaches could accelerate discovery of noncoding var...
Wendy Bickmore@wbickmor.bsky.social

It was great working with students Kun and Ryan and @hannahlong.bsky.social, combing the literature to try and find examples of bona fide disease-causing variants in non-coding elements - promoters, enhancers and silencers. www.nature.com/articles/s41...

mspielmann.bsky.social reposted

Featured in The Scientist: Dr. Alexander Hoischen discusses how long-read sequencing on the Revio system is helping end the rare disease diagnostic odyssey by filling the gaps left by short reads. Read the interview: bit.ly/4i3LKFl #PacBio #Revio #RareDisease #HiFiSequencing

mspielmann.bsky.social reposted

What regulates the urge to sleep? William Joo and colleagues identified brain regions that reflect how long mice have been awake. Strikingly, inhibiting one of these regions reduces sleep by 70%, without the major behavioral deficits associated with sleep deprivation. www.nature.com/articles/s41...

nature.comWake-activated neuronal populations that regulate sleep drive - NatureWhole-brain activity mapping, targeted cell manipulations and electrophysiology in mice identify wake-activated neuronal populations that are crucial for sleep drive and can persistently red...

mspielmann.bsky.social reposted

mspielmann.bsky.social reposted

mspielmann.bsky.social reposted

Thrilled to post thread re: new single-cell lineage of mouse embryo reconstructed w/ DNA Typewriter. One animal, zygote to late organogenesis (E13.5). Tree has 1,340,794 transcriptionally profiled, annotated tips (cells), 1,142,588 dated internal nodes, rooted at zygote 1/n

mspielmann.bsky.social reposted

🧬 New studies show how SVs downstream of FOXG1 can disrupt its regulation and contribute to a FOXG1-like NDD. Together, they reveal distinct regulatory loci and provide new insight into the locus’s 3D organisation. 👉https://buff.ly/UVhWtWk 👉https://buff.ly/Nvidv1E

mspielmann.bsky.social reposted

mspielmann.bsky.social reposted

We are shocked by the attack on Berlin’s CSD. Our thoughts are with the victims, their loved ones, and everyone affected. We are proud of our queer community and stand firmly in solidarity with them. Together, we are shaping #mdcBerlin into a place rooted in openness, respect, and mutual support.

mspielmann.bsky.social reposted

mspielmann.bsky.social reposted

mspielmann.bsky.social reposted

mspielmann.bsky.social reposted

mspielmann.bsky.social reposted

🏆 Congratulations to Tuuli Lappalainen, ESHG Award Lecturer 2026! In her Award Lecture, Professor Lappalainen will discuss the next steps in interpreting these effects and the tools that will help researchers uncover the molecular mechanisms underlying genetic variation. #Genetics #eshg2026

mspielmann.bsky.social reposted

Guillaume Canaud, Mendel Lecturer at #eshg2026! Professor Canaud is internationally recognised for his pioneering research into the molecular mechanisms of rare vascular disorders and for translating genetic discoveries into targeted therapies that are transforming patient care #Genetics #Genomics

mspielmann.bsky.social reposted

Next up, Adam Ameur shares that long-read WGS efforts are ongoing in Sweden for population genomics and clinical diagnostics. They bridge these projects by using a joint analysis framework and shared variant databases. #ESHG2026 #PacBio #ESHG

mspielmann.bsky.social reposted

Coming up today at 10:30 in Hall C: Don't miss Session C15.1! #PacBio Scientist Xiao Chen will showcase how HiFi sequencing resolves the complex D4Z4 repeat responsible for facioscapulohumeral muscular dystrophy. See you soon! #ESHG2026

mspielmann.bsky.social reposted

Replying to @ahoischen.bsky.social

Additional evidence for the fact: Long read genomes are the future of rare disease diagnostics and research (and more evidence following shortly)…

mspielmann.bsky.social reposted

Congrats to all co-authors from out HiFi-Solves EMEA consortium! www.pacb.com/hifi-solves/ This study was driven particularly by the great @bartvds.bsky.social; with important contributions from Hanno Jörn Bolz Johannes Zschocke Malte Spielmann and their teams.

lnkd.inLinkedInThis link will take you to a page that’s not on LinkedIn

mspielmann.bsky.social reposted

In 832 patients with rare genetic disease, a conclusive diagnosis was made for 160 patients (19.2%) with long-read genome sequencing and for 137 patients (16.5%) with standard-of-care testing. Full study results: https://nej.md/4e03ejh #ESHG2026

mspielmann.bsky.social reposted

👋🧬 Welcoming address #eshg2026 @ahoischen.bsky.social @eshg.bsky.social 3,171 abstracts from 95 countries: 🇬🇧🇮🇹🇹🇷🇩🇪🇪🇸 et al 👥6,048 participants: 🙋‍♂️🙋‍♀️4,812 in person 💻 🖥️1,248 online ⛅️ Fascinating word cloud from all presentation titles 🇸🇪 It’s good to be in Gothenburg! #RareDisease #Genomics

Great work showing the importance of long read sequencing for rare disease!

NEJM.org@nejm.org

In 832 patients with rare genetic disease, a conclusive diagnosis was made for 160 patients (19.2%) with long-read genome sequencing and for 137 patients (16.5%) with standard-of-care testing. Full study results: https://nej.md/4e03ejh #ESHG2026

mspielmann.bsky.social reposted

There are six different poster sessions this year, so be sure to plan your poster viewings accordingly. Alternatively, registered participants can explore all posters every day at the e-poster terminals and in the e-poster gallery on the online conference platform until November 30, 2026.

mspielmann.bsky.social reposted

It was great meeting with the talented folks who’ll be working at the Obama Presidential Center. We're excited to welcome everybody here soon!

mspielmann.bsky.social reposted

The 2026 Metagenomics SMRT Grant is now open! 🧬 Submit a 100 word proposal explaining how highly accurate long read sequencing will advance your microbiome research for a chance to win free HiFi sequencing at SeqCenter. Apply here: bit.ly/4uAtTJn #PacBio #HiFisequencing #Metagenomics

mspielmann.bsky.social reposted

Today, it was Lisa's turn to defend her PhD thesis and she did an absolutely fantastic job 😍 Especially going into full structure of the RNA Pol2 catalytic core and explaining the mutants. It was an outstanding discussion! I am really proud of her performance today 🥹

mspielmann.bsky.social reposted

Replying to @danielkaschta.bsky.social

Take-home: reanalysis after ~1.8 years gives a modest but clinically relevant diagnostic gain. Scalable workflows could help unresolved rare disease cases benefit from evolving genomic knowledge.

mspielmann.bsky.social reposted

Replying to @danielkaschta.bsky.social

Concordance analysis showed that Talos captured most manually reported P/LP findings: 80.0% concordance in singleton cases and 75.2% in trio cases, rising to 82.8% when considering proband-only findings. VUS concordance was lower, as expected for a P/LP-focused workflow.

mspielmann.bsky.social reposted

Replying to @danielkaschta.bsky.social

After a mean reanalysis interval of 660 days, manual review added 3 P/LP cases and 2 newly classified VUS. Talos recovered all 3 new P/LP findings and 1 of 2 VUS, while reducing review to ~3 candidate variants per case.

mspielmann.bsky.social reposted

Replying to @danielkaschta.bsky.social

Why this matters: genome interpretation evolves over time, but fully manual reanalysis is difficult to scale in routine diagnostics. Automated prioritisation may help make periodic reanalysis more feasible.

Excited to share our latest preprint on a head-to-head comparison of automated versus manual genome reanalysis in a real world setting. Great work by @danielkaschta.bsky.social and the entire team!

Daniel Kaschta@danielkaschta.bsky.social

Our medRxiv preprint is out: Automated versus manual reanalysis in rare disease genomics. We reanalysed 377 rare disease cases from a routine diagnostic genome sequencing cohort, comparing the established manual workflow with Talos-based automation. www.medrxiv.org/content/10.6...

mspielmann.bsky.social reposted

🚨 New preprint led by super⭐ PhD student Anthony (@amcguigan.bsky.social) 🥳 He studied homozygous deletions genome-wide using genome sequencing data in the amazing @genomicsengland.bsky.social NGRL See Anthony's 🧵for a summary 👇

mspielmann.bsky.social reposted